flavoxate has been researched along with Bladder, Overactive in 7 studies
Flavoxate: A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.
flavoxate : A carboxylic ester resulting from the formal condensation of 3-methylflavone-8-carboxylic acid with 2-(1-piperidinyl)ethanol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Overactive bladder is a syndrome of urinary frequency and urgency, with or without urge incontinence, in the absence of local pathological factors." | 2.53 | Flavoxate in the symptomatic treatment of overactive bladder: a meta-analysis. ( Mutambirwa, S; Sharma, JB; Sweeney, P; Van An, N; Vanamail, P, 2016) |
| "Flavoxate hydrochloride is an antispasmodic agent which exerts an inhibition of the phosphodiesterases, a moderate calcium antagonistic activity, and a local anesthetic effect." | 2.52 | Flavoxate: present and future. ( Arcaniolo, D; Conquy, S; Tarcan, T, 2015) |
| "Propiverine was at least as effective as oxybutynin but with a better tolerability profile even in the pediatric setting." | 2.48 | An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity. ( Artibani, W; Asimakopoulos, AD; Carone, R; Cerruto, MA; Del Popolo, G; Finazzi-Agrò, E; La Martina, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zor, M | 1 |
| Aydur, E | 1 |
| Dmochowski, RR | 1 |
| Arcaniolo, D | 1 |
| Conquy, S | 1 |
| Tarcan, T | 1 |
| Sweeney, P | 1 |
| Mutambirwa, S | 1 |
| Van An, N | 1 |
| Sharma, JB | 1 |
| Vanamail, P | 1 |
| Yamaguchi, O | 1 |
| Nishizawa, O | 1 |
| Takeda, M | 1 |
| Yokoyama, O | 1 |
| Homma, Y | 1 |
| Kakizaki, H | 1 |
| Obara, K | 1 |
| Gotoh, M | 1 |
| Igawa, Y | 1 |
| Seki, N | 1 |
| Yoshida, M | 1 |
| Asimakopoulos, AD | 1 |
| Cerruto, MA | 1 |
| Del Popolo, G | 1 |
| La Martina, M | 1 |
| Artibani, W | 1 |
| Carone, R | 1 |
| Finazzi-Agrò, E | 1 |
| Roxburgh, C | 2 |
| Cook, J | 2 |
| Dublin, N | 2 |
6 reviews available for flavoxate and Bladder, Overactive
| Article | Year |
|---|---|
Flavoxate in urogynecology: an old drug revisited.
Topics: Female; Flavoxate; Gynecology; Humans; Medication Adherence; Parasympatholytics; Urinary Bladder, Ov | 2015 |
Flavoxate: present and future.
Topics: Anesthetics, Local; Female; Flavoxate; Humans; Male; Parasympatholytics; Randomized Controlled Trial | 2015 |
Flavoxate in the symptomatic treatment of overactive bladder: a meta-analysis.
Topics: Dysuria; Flavoxate; Humans; Treatment Outcome; Urinary Bladder, Overactive; Urination; Urological Ag | 2016 |
An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.
Topics: Benzilates; Drug Administration Schedule; Female; Flavoxate; Humans; Male; Mandelic Acids; Muscarini | 2012 |
Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Cholinergic Antagonists; Dopamine Uptake | 2007 |
Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Cholinergic Antagonists; Dopamine Uptake | 2007 |
1 other study available for flavoxate and Bladder, Overactive
| Article | Year |
|---|---|
Clinical guidelines for overactive bladder.
Topics: Anti-Dyskinesia Agents; Antidepressive Agents; Behavior Control; Botulinum Toxins; Capsaicin; Cholin | 2009 |